Ventana Clinical Research Corporation

Ventana was founded in 1997 by Dr. Edward Sellers, Dr. Myroslava Romach, Dr. Neil Shear and Gail Somer after having established international reputations with more than thirty years of quality, innovative research and consulting at the University of Toronto, University Health Network, the Addiction Research Foundation and Sunnybrook and Women's College Health Sciences Centre in Toronto. Starting as a small independent research group with inpatient beds for early-phase clinical drug trials within the hospital setting, the company soon expanded in 2001 to a stand-alone facility with a 16-bed capacity and approximately 50 staff members.

The company has consistently shown growth in both revenue and resources and was recently listed as one of Canada's Fastest-Growing Companies by Profit Magazine.

Due to the tremendous success of the company, the company again expanded in 2004 to a custom-designed, dedicated clinical research facility with an inpatient capacity of 64 beds.

Contact Details: 720 King Street West, 7th Floor Toronto Ontario M5V 2T3 Canada Tel: (416) 963-4922 Fax: (416) 963-9732 Email: info@ventana-crc.com WWW: www.ventana-crc.com/

Loading...

Recent Publications by Ventana Clinical Research Corporation:
In vivo neurochemical effects induced by changes in endocannabinoid neurotransmission. Neurotropic effects of endo- and exo-cannabinoids are largely caused by...	14th April, 2007	Ventana Clinical Research Corporation, Toronto, ON, Canada.	Curr Opin Pharmacol. 2007 Feb;7(1):62-8. Epub 2006 Dec 15. DOI Direct Link
Relative abuse potential of opioid formulations in Canada: a structured field study. INTRODUCTION: While prescription opioids can improve quality of life...	16th March, 2007	Ventana Clinical Research Corporation, Toronto, Ontario, Canada.	J Opioid Manag. 2006 Jul-Aug;2(4):219-27.
Efalizumab, a reversible T-cell modulator for psoriasis. The humanized monoclonal antibody (MAb) efalizumab (Raptiva) was developed...	13th September, 2006	Sunnybrook & Women's College Health Sciences Centre, University of Toronto	J Cutan Med Surg. 2006;9 Suppl 1:4-9. DOI Direct Link
Research design strategies to evaluate the impact of formulations on abuse liability. Scheduling of a chemical drug substance under the Controlled Substances...	26th July, 2006	Ventana Clinical Research Corporation, Toronto, Canada.	Drug Alcohol Depend. 2006 Jun;83 Suppl 1:S52-62. Epub 2006 Mar 22. DOI Direct Link

BioNews Results for Ventana Clinical Research Corporation:
Diagnostics and therapeutics in partnership	Medical Device Link:  Nov 5 2008 3:12AM Matching: ventana clinical research
Diagnostics and therapeutics in partnership	IVD Technology:  Nov 5 2008 12:33AM Matching: ventana clinical research

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 1209 times since April 2007, the link to the organisation's website has been followed 301 times

Recent Search Terms used to find this page: Ventana Clinical Research | Gail Somer Ventana clinical research | clinical researcher Toronto Gail | clinical researcher Toronto Gail | site:www.bioportfolio.com ventana-crc | clinical research Toronto | DRUG RESEARCH STUDIES TORONTO | clinical research toronto | PHARMACEUTICAL RESEARCH COMPANIES IN ONTARIO | t | .

Search for more companies in Toronto

Search for more companies in Ontario

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Ventana Clinical Research Corporation